TerminatedNot Applicable

Glucose Control In Hematopoetic Stem Cell Transplant

Stopped: study terminated due to lack of enrollment

United States11 participantsStarted 2007-02

Plain-language summary

To determine whether intensive glucose control results in improved mortality and reduced hospital stay length by performing a randomized trial of intensive glucose management (blood glucose goal 110 mg/dl) using continuous IV insulin and glucose vs. non-intensive glucose management (goal 200 mg/dl)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients older than 18 * Must meet standard criteria for HSCT * If patient is known diabetic at admit the may be maintained on home sulfonylurea and insulin if randomized to the conventional arm Exclusion Criteria: * If on intensive arm patient must stop all oral hyperglycemic meds

What they're measuring

Intensive Control of Glucose Effects on Mortality in Allogenic Hematopoietic Stem Cell Transplant (HSCT)

Timeframe: 100 days

Trial details

NCT IDNCT00582036

SponsorUniversity of Oklahoma

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-05

Results submitted2011-01-06

View on ClinicalTrials.gov More Hyperglycemia trials